Loading...
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
Improved prognostic stratification of patients with TNM stage II colorectal cancer (CRC) is desired, since 20–30% of high‐risk stage II patients may die within five years of diagnosis. This study was conducted to investigate REarranged during Transfection (RET) gene promoter CpG island methylation a...
Na minha lista:
| Udgivet i: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528631/ https://ncbi.nlm.nih.gov/pubmed/24560444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.01.011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|